scispace - formally typeset
M

Michel de Chaldée

Researcher at Centre national de la recherche scientifique

Publications -  6
Citations -  306

Michel de Chaldée is an academic researcher from Centre national de la recherche scientifique. The author has contributed to research in topics: Huntingtin & Neurodegeneration. The author has an hindex of 6, co-authored 6 publications receiving 282 citations. Previous affiliations of Michel de Chaldée include Université Paris-Saclay & University of Paris-Sud.

Papers
More filters
Journal ArticleDOI

Additional support for schizophrenia linkage on chromosomes 6 and 8: A multicenter study

Dieter B. Wildenauer, +125 more
TL;DR: Results are interpreted as inconclusive but suggestive of linkage in the latter two regions, and it is concluded that multicenter follow-up linkage studies of complex disorders can help to direct research efforts toward promising regions.
Journal ArticleDOI

The striatal long noncoding RNA Abhd11os is neuroprotective against an N-terminal fragment of mutant huntingtin in vivo

TL;DR: It is confirmed that despite the presence of 2 small open reading frames (ORFs) in its sequence, Abhd11os is not translated into a detectable peptide in living cells, which indicates that the loss lncRNA Abhd 11os likely contribute to striatal vulnerability in HD.
Journal ArticleDOI

No evidence for linkage between COMT and schizophrenia in a French population.

TL;DR: A multipoint non-parametric linkage analysis and a transmission disequilibrium test were performed on 42 multiplex families genotyped for Pml I and Bcl I polymorphisms, and neither linkage nor preferential transmission of any allele or haplotype was detected.
Journal ArticleDOI

Loss of the thyroid hormone-binding protein Crym renders striatal neurons more vulnerable to mutant huntingtin in Huntington's disease

TL;DR: It is shown that overexpression of Crym in striatal medium-size spiny neurons using a lentiviral-based strategy in mice is neuroprotective against the neurotoxicity of an N-terminal fragment of mHtt in vivo, suggesting that Crym may be a key determinant of the vulnerability of the striatum.